NVO's 10% stock price rally masks deeper challenges as competition, restructuring and slower growth weigh on its outlook.

Novo Nordisk A/S rose the most in a month after its diabetes blockbuster Ozempic beat Eli Lilly & Co.’s older drug Trulicity in a real-world survey of certain US patients.

The wildly popular Ozempic drug cuts heart attack, stroke and death risk by nearly 25% in older patients, according to a new study published by Novo Nordisk and released on Thursday.

At its pharmacy, Costco now offers Ozempic and Wegovy at huge discounts, but are these GLP-1 drugs right for you?

The global GLP-1 market has been in the spotlight for the past couple of years as big pharma players realize its multi-billion-dollar potential and the untapped nature. It is currently dominated by ...

For some GLP-1 users, the road from slim to grim is short. Surveys show that nearly 12% of Americans have turned to Ozempic, Wegovy or similar drugs to lose weight, with prescriptions more than ...

The Cleveland Clinic found in a September report that individuals with a version of the gene Neurobeachin were more likely to ...

Over the past two years, drugs like Ozempic and Mounjaro have gone from quiet prescriptions for Type 2 diabetes to global household names. Thanks to celebrity testimonials, viral TikToks and endless ...

GLP-1 meds include Ozempic and Wegovy, which studies show could help reduce alcohol cravings and drug dependency.

Kathy Bates is pushing back at speculation about her recent weight loss. During an interview with Variety, the 77-year-old Oscar-winning actress shot back at critics who attributed her 100-pound ...

Ozempic cuts heart-attack risk in older patients. The wildly popular Ozempic drug cuts heart attack, stroke and death risk by nearly 25% in older patients, according to a new study released by Novo ...